ERBB2 and ductal breast carcinoma in situ: In this study, we explored gene expression profiles in HER2-positive pure DCIS and mixed invasive breast carcinomas in a spatial context with the aim of identifying clues to how HER2-positive DCIS progresses to invasive disease.